Delayed rectifier channels in human ventricular myocytes

Circulation. 1995 Dec 15;92(12):3497-504. doi: 10.1161/01.cir.92.12.3497.

Abstract

Background: Previous studies have shown that in heart there are two kinetically distinct components of delayed rectifier current: a rapidly activating component (IKr) and a more slowly activating component (IKs). The presence of IKr and/or IKs appears to be species dependent. We studied the nature of the delayed rectifier current in human ventricle in whole-cell and single-channel experiments.

Methods and results: Ventricular myocytes were obtained from hearts of patients with ischemic or dilated cardiomyopathy. Single-channel currents and whole-cell tail currents were recorded at negative potentials directly after return from a depolarizing step. Single-channel currents were measured in the cell-attached patch configuration with 140 mmol/L K+ in the pipette. In the present study, we identified a voltage-dependent channel with a single-channel conductance of 12.9 +/- 0.8 pS (mean +/- SEM, n = 5) and a reversal potential near to the K+ equilibrium potential, suggesting that the channel is selective to K+ ions. Channel activity was observed only after a depolarizing step and increased with the duration and amplitude of the depolarization, indicating time- and voltage-dependent activation. Activation at +30 mV was complete within 300 milliseconds, and the time constant of activation, determined in the whole-cell configuration, was 101 +/- 25 milliseconds (mean +/- SEM, n = 4). The voltage dependence of activation could be described by a Boltzmann equation with a half-activation potential of -29.9 mV and a slope factor of 9.5 mV. The addition of the class III antiarrhythmic drug E-4031 completely blocked channel activity in one patch. No indications for the presence of IKs were found in these experiments.

Conclusions: The conformity between the properties of IKr and those of the K+ channel in the present study strongly suggests that IKr is present in human ventricle.

MeSH terms

  • Action Potentials
  • Anti-Arrhythmia Agents / pharmacology
  • Cardiomyopathy, Dilated / pathology
  • Cells, Cultured
  • Heart Ventricles
  • Humans
  • Myocardial Ischemia / pathology
  • Myocardium / cytology*
  • Myocardium / metabolism
  • Piperidines / pharmacology
  • Potassium Channels / drug effects
  • Potassium Channels / physiology*
  • Pyridines / pharmacology

Substances

  • Anti-Arrhythmia Agents
  • Piperidines
  • Potassium Channels
  • Pyridines
  • E 4031